Citi lowered the firm’s price target on Community Health to $6 from $7 and keeps a Buy rating on the shares. The company reported an inline Q3 EBITDA print and lowered guidance as favorable labor management is running against a pressured physician environment and revenue mix nuances as the system normalizes, the firm said in a research note on Friday.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CYH: